MONTREUX EQUITY PARTNERS
Founded in 1993, Montreux Equity Partners is a private investment firm focused on making growth capital investments in the leading companies of tomorrow. Our portfolio companies address the most compelling domestic and global trends in health. We are currently investing out of our fifth fund. We focus on commercial stage companies that possess highly differentiated products, technologies, and services. At the time of investment, a company will typically have $5 to $50 million in revenues. Our capital fuels product expansion, new market entry, and strategic acquisitions.
MONTREUX EQUITY PARTNERS
Social Links:
Industry:
Finance Financial Services FinTech
Founded:
1993-01-01
Status:
Active
Contact:
(650) 234-1200
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Google Tag Manager Mobile Non Scaleable Content Nginx Microsoft Exchange Online
Similar Organizations
Tradovate
Tradovate is an online futures brokerage firm dedicated to meeting the needs of active retail traders.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-06 | Tebra | Montreux Equity Partners investment in Series B - Tebra | 72 M USD |
| 2022-06-14 | KEO World | Montreux Equity Partners investment in Venture Round - KEO World | 20 M USD |
| 2022-03-28 | FinPay | Montreux Equity Partners investment in Series D - FinPay | 15 M USD |
| 2020-11-12 | FinPay | Montreux Equity Partners investment in Series C - FinPay | 5 M USD |
| 2020-10-08 | TigerConnect | Montreux Equity Partners investment in Series D - TigerConnect | 11.5 M USD |
| 2019-05-09 | Pulmonx | Montreux Equity Partners investment in Series G - Pulmonx | 65 M USD |
| 2019-05-03 | Crown Laboratories | Montreux Equity Partners investment in Private Equity Round - Crown Laboratories | N/A |
| 2018-10-30 | GC Aesthetics | Montreux Equity Partners investment in Venture Round - GC Aesthetics | 97 M USD |
| 2018-03-06 | Sonoma Pharmaceuticals | Montreux Equity Partners investment in Post-IPO Equity - Sonoma Pharmaceuticals | 4.6 M USD |
| 2017-07-21 | Colorescience | Montreux Equity Partners investment in Series C - Colorescience | 15 M USD |